PODCAST: Why a health care journalist chose active surveillance for prostate cancer

Michael Joyce produces multimedia for HealthNewsReview.org and tweets as @mlmjoyce

We have written dozens of stories and reviews on screening for prostate cancer. But once a man is diagnosed he is faced with a complicated — and often intimidating — menu of treatment choices.

Left: Howard Wolinsky, Right: Dr. Chris Warlick

As a health care journalist, Howard Wolinsky made it his business to understand these choices when he was diagnosed with prostate cancer. He chose no immediate treatment. More specifically, he chose an approach called “active surveillance,” which has gradually become more widely utilized by men with less aggressive disease.

Stories of men who choose active surveillance are not often told. Our news media commonly emphasize the experience of men who choose more aggressive treatment approaches. But that emphasis may reflect the incentives of commercial interests in our health care system rather than what is best for patients. That’s why we think it’s important to tell this story.  

Besides Wolinsky, this podcast features Dr. Chris Warlick, a urologist who runs an active surveillance program at the University of Minnesota. Dr. Warlick and Mr. Wolinsky touch on several topics in this roughly 15-minute podcast including the basics regarding prostate cancer, our approach to cancer and risk in this country, the potential of truly shared decision making, what active surveillance is and is not, and the difference between active surveillance and watchful waiting. Howard also tells a compelling story of being asked to share his story with urologists at a cancer conference, and then almost going unheard.

More than one urologist has referred to Howard Wolinsky as a “poster child” for active surveillance. But he could also be seen as a role model. It’s inspiring to see how he has educated himself so he could take a more proactive, rather than passive role, in his own health care. Following his lead we offer the following resources for those of you who might want to dig deeper.

  • Finally, it’s almost impossible to talk about anything related to prostate cancer and not bring up the issue of screening. Our publisher and founder, Gary Schwitzer, considers this article a must-read

You can find all of our podcasts on this index page – 27 (so far) and counting…

You might also like

Comments (1)

We Welcome Comments. But please note: We will delete comments left by anyone who doesn’t leave an actual first and last name and an actual email address.

We will delete comments that include personal attacks, unfounded allegations, unverified facts, product pitches, or profanity. We will also end any thread of repetitive comments. Comments should primarily discuss the quality (or lack thereof) in journalism or other media messages about health and medicine. This is not intended to be a forum for definitive discussions about medicine or science. Nor is it a forum to share your personal story about a disease or treatment -- your comment must relate to media messages about health care. If your comment doesn't adhere to these policies, we won't post it. Questions? Please see more on our comments policy.

E. Michael D. Scott

March 17, 2017 at 7:27 am

We are always pleased to see HNR covering the topic of prostate cancer. Thanks for helping to educate the media better about the increasing role of active surveillance in the management of the commonest form of cancer in men … and please click here to see our coverage of your coverage!